None
Quote | Evotec SE (NYSE:EVO)
Last: | $ |
---|---|
Change Percent: | 0.08% |
Open: | $12.61 |
Close: | $12.62 |
High: | $12.62 |
Low: | $12.55 |
Volume: | 19,443 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Evotec SE (NYSE:EVO)
Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimiz...
2024-06-20 07:35:13 ET More on Evotec SE Evotec SE (EVO) Q1 2024 Earnings Call Transcript Evotec SE 2024 Q1 - Results - Earnings Call Presentation Evotec SE (EVO) Q4 2023 Earnings Call Transcript Evotec to exit gene therapy business, close Austria site ...
Message Board Posts | Evotec SE (NYSE:EVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $EVTCY News Article - Evotec Launches 'BeLAB2122', Translating Academic Innovation from | whytestocks | investorshangout | 04/13/2021 3:40:53 PM |
whytestocks: $EVTCY News Article - Evotec, Sensyne Health, The University Of Oxford, OSI, and OUI Cr | whytestocks | investorshangout | 06/24/2019 1:35:40 PM |
Emylers: EVTCY Financials Monday, July 14, 2014 10:38:01 PM Evotec AG EVTCY is either non-reporting | Emylers | investorshangout | 07/15/2014 2:38:03 AM |
Stock_Tracker: Latest Evotec Ag Ads (EVTCY) Headlines Will Johnson & Johnson's New Alzheimer's Partn | Stock_Tracker | investorshangout | 03/09/2014 11:23:23 PM |
chartguy89: EVTCY 11.18 Stock Charts $EVTCY 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 9:01:57 AM |
News, Short Squeeze, Breakout and More Instantly...
Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimiz...
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research HAMBURG, GERMANY / ACCESSWIRE / June 12, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/T...
Most agenda items adopted with great majority Annual General Meeting 2024 elects Dr Duncan McHale and Wesley Wheeler to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka HAMBURG, GERMANY / ACCESSWIRE / June 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDA...